About MicroVascular Tissues
MicroVascular Tissues is a private company based in Jamaica Plain, Massachusetts. It has reported $9,949,304 raised in four offerings on Form D since May 2014. Its chief executive is Glen Gong.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 23, 2023 | Mar 10, 2023 | $4,112,304of $6.1M target | 15 | $274K | EquityRule 506(b) | Form D ↗ |
| Aug 31, 2018 | Sep 13, 2018 | $3,500,000of $8.0M target | 21 | $166K | EquityRule 506(b) | Form D ↗ |
| Dec 16, 2016 | Dec 20, 2016 | $2,332,000of $3.5M target | 9 | $259K | CONVERTIBLE NOTESRule 506(b) | Form D ↗ |
| Mar 10, 2014 | May 13, 2014 | $5,000fully sold | 7 | $714 | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $9,949,304 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on MicroVascular Tissues's Form D filed Mar 10, 2023.
GG
Glen Gong
President and Chief Executive Officer, director
DP
Dale Peterson
Director
KO
Kevin Ohashi
Director
Earlier filings also listed Kevin Oshasi (executive officer and director, last listed Aug 2014) and Brent Atkinson (vice president & chief operating officer, last listed May 2014).